產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CHFR抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CHFR抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CHFR
Cat. Number:
Anti-CHFR抗體KL-4272R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
A number of human Anti-CHFR抗體cancers are sensitive to mitotic stress, implying checkpoint defects. Many proteins that contain forkhead-associated (FHA) domains are cell cycle checkpoints and CHFR is one such protein. It has a FHA and ring finger domain within its N terminus. Within its C terminus, CHFR contains a cysteine-rich region that did not display significant similarity to any protein in the GenBank database, but is highly conserved between humans and mice. It has been concluded that CHFR defines a checkpoint that delays entry into metaphase in response to mitotic stress. It has been found CpG methylation-dependent silencing of CHFR expression occurs in 45% of cancer cell lines, 40% of primary colorectal cancers, 53% of colorectal adenomas, and 30% of primary head and neck cancers.
Also known as:
Checkpoint with forkhead Anti-CHFR抗體and ring finger domains; Checkpoint with forkhead and RING finger domains protein; E3 ubiquitin protein ligase CHFR; EC 6.3.2.; RING finger protein 196; RNF 116; RNF 196; RNF116; RNF196; Ubiquitin ligase protein; CHFR_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CHFR.
●
Predicted Molecular Weight: 73 kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-CHFR抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CHFR抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-CHFR抗體must be determined by the end user.
kl229Ra01 單Ig IL1相關(guān)受體(SIGIRR)多克隆抗體 Polyclonal Antibody to Single Ig IL1 Related Receptor (SIGIRR)
kl330Hu01 POTE錨蛋白域家族成員J(POTEJ)多克隆抗體 Polyclonal Antibody to POTE Ankyrin Domain Family, Member J (POTEJ)
kl061Ov01 白介素15(IL15)多克隆抗體 Polyclonal Antibody to Interleukin 15 (IL15)
kl063Rb51 白介素17(IL17)多克隆抗體 Polyclonal Antibody to Interleukin 17 (IL17)
kl281Ra01 B-細(xì)胞激活因子受體(BAFFR)多克隆抗體 Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR)
kl488Ra01 角蛋白5(KRT5)多克隆抗體 Polyclonal Antibody to Keratin 5 (KRT5)
kl489Ra01 角蛋白4(KRT4)多克隆抗體 Polyclonal Antibody to Keratin 4 (KRT4)
kl492Ra01 角蛋白1(KRT1)多克隆抗體 Polyclonal Antibody to Keratin 1 (KRT1)
kl517Ra01 角蛋白15(KRT15)多克隆抗體 Polyclonal Antibody to Keratin 15 (KRT15)
kl519Cp01 載脂蛋白A1(APOA1)多克隆抗體 Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl560Ca01 表皮生長(zhǎng)因子(EGF)多克隆抗體 Polyclonal Antibody to Epidermal Growth Factor (EGF)
kl763Mu01 叉頭框蛋白C1(FOXC1)多克隆抗體 Polyclonal Antibody to Forkhead Box Protein C1 (FOXC1)
kl774Mu01 糖皮質(zhì)**受體α(GRα)多克隆抗體 Polyclonal Antibody to Glucocorticoid Receptor Alpha (GRa)
kl782Ca01 碳酸酐酶Ⅱ(CA2)多克隆抗體 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl782Ov01 碳酸酐酶Ⅱ(CA2)多克隆抗體 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl782Rb51 碳酸酐酶Ⅱ(CA2)多克隆抗體 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl783Mu01 補(bǔ)體因子P(CFP)多克隆抗體 Polyclonal Antibody to Complement Factor P (CFP)
